Efficacy News and Research

RSS
CTT's Calmare Pain Therapy Treatment shows promise against CIPN

CTT's Calmare Pain Therapy Treatment shows promise against CIPN

Widely used cancer drug bevacizumab can lead to proteinuria, kidney damage: Study

Widely used cancer drug bevacizumab can lead to proteinuria, kidney damage: Study

Helix BioPharma third-quarter revenues increase 20.6%

Helix BioPharma third-quarter revenues increase 20.6%

Bevacizumab increases risk for proteinuria in cancer patients

Bevacizumab increases risk for proteinuria in cancer patients

Shenzhen Beike Biotechnology forms joint venture with SiriCell Technologies

Shenzhen Beike Biotechnology forms joint venture with SiriCell Technologies

Phase 3 AVERROES clinical trial of apixaban for atrial fibrillation closes early due to clear evidence of efficacy

Phase 3 AVERROES clinical trial of apixaban for atrial fibrillation closes early due to clear evidence of efficacy

FDA advisory committee recommends approval of Novartis' FTY720 for relapsing MS

FDA advisory committee recommends approval of Novartis' FTY720 for relapsing MS

EC approves Nivestim for prevention of FN

EC approves Nivestim for prevention of FN

Onset Therapeutics expands sales force by over 50% in 2010

Onset Therapeutics expands sales force by over 50% in 2010

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

Boston Scientific's TAXUS Element Paclitaxel-Eluting Coronary Stent System launched in Europe

Neutralizing inhibitory molecules does not improve regeneration in damaged spinal axons

Neutralizing inhibitory molecules does not improve regeneration in damaged spinal axons

MAP Pharmaceuticals to present new analyses from LEVADEX Phase 3 trial for acute migraine at 52nd AHS

MAP Pharmaceuticals to present new analyses from LEVADEX Phase 3 trial for acute migraine at 52nd AHS

Preclinical data of VB-201 to be presented at EULAR Annual European Congress of Rheumatology

Preclinical data of VB-201 to be presented at EULAR Annual European Congress of Rheumatology

UC emergency medicine assistant professor compares efficacy of two seizure medications to prevent SE

UC emergency medicine assistant professor compares efficacy of two seizure medications to prevent SE

Aeterna Zentaris reports final results on clinical activity of perifosine for metastatic colorectal cancer

Aeterna Zentaris reports final results on clinical activity of perifosine for metastatic colorectal cancer

Cognitive-behavioral, skills-based treatment intervention program shows promise for teenagers with IBD

Cognitive-behavioral, skills-based treatment intervention program shows promise for teenagers with IBD

Sialidase improves nerve regrowth, motor recovery and nervous system function: Researchers

Sialidase improves nerve regrowth, motor recovery and nervous system function: Researchers

TF2 bispecific antibody pretargeted therapy prolongs survival in animal model of human colonic cancer

TF2 bispecific antibody pretargeted therapy prolongs survival in animal model of human colonic cancer

CoLucid's lasmiditan NAAMA effective in treatment of acute migraine attacks

CoLucid's lasmiditan NAAMA effective in treatment of acute migraine attacks

New information to help patients make important decision regarding stem cell treatments

New information to help patients make important decision regarding stem cell treatments

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.